Photo of Audrey Paul

Audrey Paul

  • ASSISTANT PROFESSOR Emergency Medicine
Print ProfilePrint Profile


  • Pediatric Emergency Medicine

  • American Board of Pediatrics

Clinical Focus

  • Pediatric Emergencies


  • MD, Mount Sinai Hospital

  • Residency, Pediatrics
    Mount Sinai Hospital

  • Fellowship, Pediatric Emer Med
    Columbia University Medical Center


    Dr. Paul grew up in NYC, attended Harvard College and completed her medical and graduate training at Mount Sinai Medical School. 

    Academic interests include community outreach, asthma prevention and management, wound healing and resident education.

    Regional / National Committees / Advisory Boards:


    Past Chair, Section on Pediatric Emergency Medicine, ACEP

    Chair, Micro-site Advisory Board, Pediatric Emergency Medicine ACEP

    EMSC, National Resource Center

    SAEM, Social Media Committee

    Supersprowtz Advisory Board


  • -
    Bela Shick Award in Pediatrics

  • -
    AOA Hirschhorn Pediatrics Award


Research interests include adverse behavioral effects of steroids in treatment of pediatric asthma, ED management of pediatric UTI, resident education.

Also interested in utilization of child life in pediatric and adult emergency medicine departments


Zelicof-Paul A, Lockridge-Smith A, Schnadower D, E. Controversies in rapid sequence intubation in children. Curr Opin Pediatr 2005 June; 17(3): 355-362.

Zelicof A, Protopopov V, E. Two Separate Functions are Encoded by the Carboxyl-terminal domains of the Yeast Adenylyl Cyclase Associated Protein and its Mammalian Homologs;Dimerization and Actin Binding. Journal of Biological Chemistry 1996; 271(30): 18243-18253.

Zelicof A, Gatica J, Gerst JE. Molecular Cloning and Characterization of a Mammalian Homolog of CAP-the adenylyl cyclase associated Protein from S.Cerevisae. Journal of Biological Chemistry 1993; 268(18): 13448-13453.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Paul did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.

Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.

Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central